LUNG vs BVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

LUNG

32.9
AI Score
VS
BVS Wins

BVS

59.0
AI Score

Investment Advisor Scores

LUNG

33score
Recommendation
SELL

BVS

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG BVS Winner
Revenue 66.18M 427.74M BVS
Net Income -32.13M 42.54M BVS
Gross Margin 77.3% 68.6% LUNG
Net Margin -48.5% 9.9% BVS
Operating Income -29.50M 37.24M BVS
ROE -93.9% 17.7% BVS
ROA -29.2% 6.3% BVS
Total Assets 110.21M 673.43M BVS
Cash 52.69M 30.71M LUNG
Debt/Equity 1.11 0.88 BVS
Current Ratio 4.05 1.68 LUNG
Free Cash Flow -18.51M 47.60M BVS

Relative Price Performance (Last 90 Days)

LUNG 1M: +55.6% · 3M: +22.3% BVS 1M: -17.4% · 3M: -19.7%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62

RSI (14): 62.5 · Price: $2.80

BVS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 36

RSI (14): 36.0 · Price: $11.18

Fundamentals Snapshot

Metric LUNG BVS
Market Cap — —
Forward P/E -3.1 12.6
Trailing P/E — 13.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.7%
Operating Margin -0.3% 0.1%
EPS -1.01 0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BVS is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.